WBR0085

Author	PageAuthor::Aditya Govindavarjhulla
Exam Type	ExamType::USMLE Step 2 CK
Main Category	MainCategory::Pediatrics
Sub Category	SubCategory::Infectious Disease, SubCategory::Pediatrics
Prompt	Prompt::A 26 year old mother was seen by an Infectious disease consult team on the 2 second day after delivery. She has positive test results for VDRL and FTA-ABS. Which test should be ordered by the team before starting treatment in the infant?
Answer A	AnswerA::Maternal serum – VDRL
Answer A Explanation	AnswerAExp::Quantitative tests must be performed on infants born to reactive mothers, rather than testing the mother.
Answer B	AnswerB::Infant serum – VDRL
Answer B Explanation	AnswerBExp::Infant serum-VDRL is a quantitative non-treponemal serologic test. Infant serum VDRl or RPR should be performed on infants born to reactive mothers.
Answer C	AnswerC::Umbilical cord – VDRL
Answer C Explanation	AnswerCExp::Umbilical cord blood cannot be tested due to maternal and fetal blood mixing, which may give false positive results.
Answer D	AnswerD::Infant serum – FTA-ABS
Answer D Explanation	AnswerDExp::Infant serum FTA-ABS is a treponemal test and non-treponemal test (RPR and VDRL) should be performed on a infant of reactive mother.
Answer E	AnswerE::
Answer E Explanation	AnswerEExp::
Right Answer	RightAnswer::D
Explanation	[[Explanation::Explanation: All infants born to mothers who have reactive non-treponemal and treponemal test results should be evaluated with a quantitative non-treponemal serologic test (RPR or VDRL) performed on infant serum, because umbilical cord blood can become contaminated with maternal blood and yield a false-positive result. Conducting a treponemal test (i.e., TP-PA, FTA-ABS, EIA, or chemiluminescence assay) on a newborn’s serum is not necessary. Educational Objective: References: ]]
Approved	Approved::Yes
Keyword
Linked Question	Linked::
Order in Linked Questions	LinkedOrder::